Member Info for BoNidel

Indeed it is but the current ask is 0.7

I am trying to buy more but can also see that the BID is 0.30 but one of the brokers looking to pick up 59,900 shares at that price.

For some reason the spread has widened but also there is more appetite.

Not sure how long before the wider market realises you can buy this again now.

What is crazy is (correct me if I’m wrong).

If you buy one accustem share now it costs in the region of 75 cents - call it 60p sterling for arguments sake.

For 60p (ish) you get one new accustem share.

Prior to the consolidation, that one share would have been worth 10 US ADR accustem shares or 20 UK accustem shares.

To get accustem entitlements, you had to hold tils share at the Ex date in October 2020

For one accustem share now, you would have had to have held 20 TILS shares at a price of around £1.80 per share (again correct me if I’m wrong).

So for a 60p purchase of accustem now for one share, you would have needed 20 tils shares equivalent at a cost of £1.80 / share so £36.

So if you buy 1000 accustem shares now for a cost of say £600 sterling (not including other fees - dealing etc),

You would have had to have owned £21,600 worth of tils shares at ex-date for something you can now buy for £600..

I know accustem is worthless currently, but can anyone else see the potential value here or discount if indeed accustem does actually come to fruition?

Managed to pick some more up today! They were available with HL for phone trades. Blind gambling but If even a fraction of the $200m valuation given by HC wainwright (it was it zacks)? Then maybe a bargain..

Time will tell

Only thing I must add with accustem, is that although I’m furious about the whole debacle, he may well have held it off in the interests of shareholders at ex date. What I mean by that, is the biotech sector has had an appalling year & that perhaps it would have been a poor time to list it.

Sometimes the doctor orders medicine in your best interests, even though you may hate it!

Hope I’m right…

Any sign of it or have we just all resigned to that fact we have been diddled?

Mad!

Chairman announces purchase of shares. Could buy those shares with his consultation fee from accustem! If GC keeps this up for a few years and the SP slides more he will own 99% of it!.

I really hope I’m wrong but I’ve been saying that for probably 18 months now, it honestly looks like the biggest shafting I’ve seen for years! Can’t believe I was naive enough to see genuity in some of the BOD and interviews etc. Expensive lesson

This really does appear to be as dead as one. Having to bottom drawer this even though I have a fair lump of them.

Seriously feel sorry for some of the investors that were diddled here, my average is probably a lot lower than many and I’m still at a fair loss.

Just wish accustem would do something decent to pull us out of this death spiral.

Desperately tried to buy earlier. Could indeed be the bargain if a lifetime.

Tried HL, spreadex, IG, saxo bank, interactive brokers.

Just doesn’t seem to be an avenue to buy

What difference does it make? I’m seriously p*asked off with the whole debacle but the consolidation makes NO DIFFERENCE. If the consolidation was 10000000000000000000/1 you would still own the same share of the company. COME ON WORK IT OUT.

We don’t know what the price is yet until the Nasdaq listing. I have desperately been trying to buy the last few days but have not found an avenue, if anyone knows what UK broker will facilitate an accustem trade PLEASE LET ME KNOW. It’s blind gambling but I’m willing to take a bigger chance .

What are you talking about? If they did 1000/1 consolidation please let me know what difference it would make?

I notice yesterday they uplifted to OTCQB. Be interesting to see what happens now.

If wonder if they are likely to get a big placing at a big price from an interested party?

Market cap is like $13m currently, HC wainwright previously valued it “conservatively” at around $280m. We are at less than 5% of that valuation.

People constantly harping on about consolidation 20/1 etc need to understand that it doesn’t really make that much difference. If GC previously owned 40% of accustem, and his are now 20/1 consolidation, he still owns around 40%…

The recent private tils placing could be seen to be massive dilution at a low price but I’m not too sure on the details of that exactly.

This could be bargain territory now but also blind gambling. You had to hold around £2 worth of tils shares to get accustem previously, now you could buy it for less than 6p equivalent?

Who knows, but hopefully we find out soon..

What I mean, is until the Nasdaq listing & a potential placing, we don’t know the real price?

Hopefully it’s not too long now. Someone mentioned around 2 weeks, wasn’t that around 2 weeks ago?..

Please feel free to correct me if I’m wrong, but the current accustem price doesn’t really have anything to do with the price of fish.

When they finally IPO, a price will be decided then & will reflect a more realistic value.

Personally, if stemprinter isn’t a fad then I would expect exact sciences To acquire this inline with their strategy. The fact they have $1bn cash on hand makes it feasible as well.

The HC Wainwright valuation was previously circa $280m (10% of the genomic health taker over value) and I think we need to wait a little longer to see the truth here.

It is pure gambling, but potentially the current SP could be really cheap IF you are able to buy. I bought another 10,000 old accustem shares (1000 new) for about £2k last year. Had I held tils to get entitlements I would have had to have around £40k worth of tils shares just for that entitlement at the time?

It certainly is blind gambling, im furious with the tils handling of pretty much everything & the BOD lack of commas. I have lost a pile on spread bets and am sick and tired of this POS but think the MS trial & impending accustem IPO could really change the landscape.

We will soon find out but there could be some excellent value at these prices, regardless of the terrible Comms/PR and apparent shafting by the BOD

Hello all, do we know if the placing was done pre or post split? It would appear to be post split meaning that if they bought 1.3m shares post split then they may have diluted accustem by 10%+ for the sale of a $2.7m dollar consideration. Am I missing something her or have we been shafted again by the BOD? Didn’t accustem Demerge with £1m from tils? Why didn’t this placing need to be done?..

Current price is closer to 40p equivalent uk??…

Anyone want to take a bet on what this will relist for?

Wrong page

When this finally relists?

If successful, what kind of MCAP would you expect?

HL still not allowing me to trade tils shares on Nasdaq.

No word from the BOD.

Scumbags

Exactly what I was thinking.

Same sh*t with the fireside chats, “foralumab is the only…. Blah blah blah”

Won’t answer difficult questions about Accustem etc, constantly changing the story, the tech they have is now being used for different reasons.

Unless there’s something big behind the scenes, we have literally all been duped here. The carrot dangling of JV, or M&A Has long faded, I think that’s why we are all still here, just incase something big was to happen. It’s FOMO that keeps a lot oF PI’s involved and stops them questioning what In hindsight were massive warning signs.

The whole sector has performed terribly, but TILS and the management really are in a league of their own.